跳至主要内容
临床试验/NCT05448365
NCT05448365招募中不适用

The Use of Vitamin D in Combination With Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in the Treatment of Women With Uterine Fibroid

Lo.Li.Pharma s.r.l2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Diameter

研究概览

简要总结

The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6.

The patients will be evaluated at baseline and after three months of treatment with placebo or product.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The study will be a double-clind, placebp-controlled trial

入排标准

年龄范围
30 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids
  • eligible for surgery
  • symptoms like menometrorrhagia or pelvic pain

排除标准

  • currently pregnant or breastfeeding
  • suspect of malignancy
  • diagnosis of cancer

研究组 & 干预措施

EGCG, Vit D, DCI, Vit B6

Active Comparator

Women with uterine fibroids randomized to treatment group

干预措施: Epigallocatechin gallate, Vitamin D, Vitamin B6, D-chiro-inositol (Dietary Supplement)

Placebo

Placebo Comparator

Women with uterine fibroids randomized to placebo group

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Diameter

时间窗: 3 months

Greater diameter of the diagnosed uterine fibroids

次要结局

  • Volume(3 months)
  • Need for surgery(3 months)
  • pVEGF-R(3 months)
  • Marker of cellular proliferation(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Vitamin D, Epigallocatechin Gallate,... | 临床试验